Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed
- PMID: 16444796
- DOI: 10.1002/pds.1213
Development of the Vaccine Analytic Unit's research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed
Abstract
Purpose: In 2002, the Centers for Disease Control and Prevention established the Vaccine Analytic Unit (VAU) in collaboration with the Department of Defense (DoD). The focus of this report is to describe the process by which the VAU's anthrax vaccine safety research plan was developed following a comprehensive review of these topics.
Methods: Public health literature, surveillance data, and clinical sources were reviewed to create a list of adverse events hypothesized to be potentially related to anthrax vaccine adsorbed (AVA). From this list, a consensus process was used to select 11 important research topics. Adverse event background papers were written for each of these topics, addressing predetermined criteria. These were independently reviewed and ranked by a National Vaccine Advisory Committee (NVAC) workgroup. The adverse events included in the final priority list will be the subject of observational or other post marketing surveillance studies using the Defense Medical Surveillance System (DMSS) database.
Results: A review of various information sources identified over 100 potential adverse events. The review process recommended 11 topics as potentially warranting further study. The NVAC workgroup identified the following adverse event topics for study: arthritis, optic neuritis, and Stevens-Johnson syndrome/Toxic epidermal necrolysis. Two additional topics (systemic lupus erythematosus (SLE) and multiple, near-concurrent military vaccinations) were added in response to emerging public health and military concerns.
Conclusions: The experience described, while specific for establishing the VAU's research agenda for the safety of the current anthrax vaccine, may be useful and adapted for research planning in other areas of public health research.
Copyright (c) 2006 John Wiley & Sons, Ltd.
Similar articles
-
Anthrax vaccination and risk of optic neuritis in the United States military, 1998-2003.Arch Neurol. 2006 Jun;63(6):871-5. doi: 10.1001/archneur.63.6.871. Arch Neurol. 2006. PMID: 16769869
-
An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):393-401. doi: 10.1002/pds.1085. Pharmacoepidemiol Drug Saf. 2005. PMID: 15717323
-
Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. doi: 10.1002/pds.936. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386719 Review.
-
Gastrointestinal adverse reactions following anthrax vaccination: an analysis of the Vaccine Adverse Events Reporting System (VAERS) database.Hepatogastroenterology. 2004 May-Jun;51(57):762-7. Hepatogastroenterology. 2004. PMID: 15143911
-
Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).Pharmacoepidemiol Drug Saf. 2002 Apr-May;11(3):189-202. doi: 10.1002/pds.712. Pharmacoepidemiol Drug Saf. 2002. PMID: 12051118 Review.
Cited by
-
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019.MMWR Recomm Rep. 2019 Dec 13;68(4):1-14. doi: 10.15585/mmwr.rr6804a1. MMWR Recomm Rep. 2019. PMID: 31834290 Free PMC article.
-
Vaccination and risk of lone atrial fibrillation in the active component United States military.Hum Vaccin Immunother. 2019;15(3):669-676. doi: 10.1080/21645515.2018.1549453. Epub 2019 Jan 8. Hum Vaccin Immunother. 2019. PMID: 30444675 Free PMC article.
-
Recent developments in the understanding and use of anthrax vaccine adsorbed: achieving more with less.Expert Rev Vaccines. 2016 Sep;15(9):1151-62. doi: 10.1586/14760584.2016.1162104. Epub 2016 Mar 25. Expert Rev Vaccines. 2016. PMID: 26942655 Free PMC article. Review.
-
Anthrax vaccination strategies.Mol Aspects Med. 2009 Dec;30(6):490-502. doi: 10.1016/j.mam.2009.08.006. Epub 2009 Sep 1. Mol Aspects Med. 2009. PMID: 19729034 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical